Chemours Cc has been set to give his last quarter-winning report on Tuesday 2025-08-05. This is what investors should know before the announcement.
Analysts estimate that chemours one profit per share (EPS) of $ 0.46.
Anticipation surrounds the announcement of Chemours, where investors hope to hear about both estimates and receiving positive guidelines for the next quarter.
New investors must understand that although profit performance is important, market reactions are often powered by guidance.
Income history snapshot
In the last quarter, the company reported a missed profit per share by $ 0.07, which led to a decrease of 9.92% in the share price on the next day.
Here is a look at the performance of Chemours and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS estimate | 0.20 | 0.16 | 0.28 | 0.57 |
| EPS Actual | 0.13 | 0.11 | 0.40 | 0.38 |
| Price change % | -10.0% | -2.0% | -3.0% | -12.0% |
Stock performance
Shares of Chemours acted at $ 11.5 from 01 August. During the last period of 52 weeks, shares fall by 34.62%. Since these returns are generally negative, shareholders in the long term are probably Bearish in this profit release.
Insights shared by analysts on Chemours
Insight into market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights into chemours.
The consensus assessment for Chemours is neutral, derived from 7 analysts. An average price objective of one year of $ 14.86 implies a potential benefit of 29.22%.
Compare ratings with competitors
The comparison of the analyst reviews and average 1-year price targets of mineral technologies, Huntsman and Vegity, three prominent players in industry, provides insights for their relative performance expectations and market positioning.
- Analysts currently prefer a buy-process for mineral technologies, with an average 1-year price target of $ 84.0, which suggests a potential benefit of 630.43%.
- Analysts currently prefer a neutral process for Huntsman, with an average price objective of 1 year of $ 11.07, which suggests a potential disadvantage of 3.74%.
- Analysts currently prefer a neutral trajectory, with an average price objective of 1 year of $ 43.0, which suggests a potential benefit of 273.91%.
Summary of Peer Analysis
The summary of the Peer analysis presents essential statistics for mineral technologies, Huntsman and GEGY, reveal their respective classification within industry and offering valuable insights into their market positions and comparative performance.
| Company | Conformity | Revenue growth | Profit | Return to equity |
|---|---|---|---|---|
| Chemours | Neutral | 0.44% | $ 236 million | -0.68% |
| Minerals Technologies | Buy | -2.27% | $ 136.90 million | 2.79% |
| Hunter | Neutral | 3.40% | $ 201m | -5.47% |
| Intake | Neutral | -16.50% | $ 113.40 million | 9.54% |
Main collection meals:
Chemours is at the bottom for sales growth with his colleagues. It is in the middle for rough profit. Chemours is at the bottom for return to equity compared to his colleagues.
About Chemours
The Chemours Co is a supplier of chemicals. It provides tailor -made solutions with a wide range of industrial and special chemical products for different markets, including coatings, plastics, cooling, air conditioning, etc. The operational segments of the company include titanium technologies, thermal and specialized solutions and advanced performance materials. It generates maximum income from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TIO2 pigment, a premium white pigment that is used to provide whiteness, brightness, coverage, sustainability, efficiency and protection in various applications. Geographically, the company generates a majority of its income from Noord -America.
Unraveling Chemours financial story
Market capitalization analysis: Above the industrial benchmarks, the market capitalization of the company emphasizes a remarkable size, indicating a strong presence on the market.
Turnover growth: During the 3 -month period, Chemours showed positive achievements, which means that a turnover growth of 0.44% From March 31, 2025. This reflects a substantial increase in the top positions of the company. Compared to his colleagues, the company reached a growth rate higher than the average among colleagues in the material sector.
Net margin: The net margin of Chemours surpasses the standards of the industry and emphasizes the exceptional financial performance of the company. With an impressive -0.29% Netto margin, the company effectively manages the costs and achieves strong profitability.
Return on Equity (roe): The roe of Chemours surpasses the industry standards and emphasizes the exceptional financial performance of the company. With an impressive -0.68% Roe, the company makes effective use of shareholders share capital.
Return on assets (ROA): The ROA from Chemours stands out and surpasses the industrial averages. With an impressive ROA from -0.05%The company shows effective use of assets and strong financial performance.
Debt management: The debt-equity ratio of Chemours surpasses the standards of the industry and is up 7.57. This suggests that the company has a considerable number of debts, making potential financial challenges.
To follow all income releases for chemours, visit their profit calendar on our site.
This article was generated by Benzinga’s automated content -engine and assessed by an editor.
#upcoming #winning #report #Chemours #Chemours #NYSE